Lista de obras -

6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease.

artículo científico publicado en 2002

A Noninvasive Method to Assess Mucosal Healing in Patients* With Crohn’s Disease.

artículo científico publicado en 2018

A Personalized Approach to Managing Inflammatory Bowel Disease

artículo científico publicado en 2016

A call for investment in education of US minorities in the 21(st) century.

artículo científico publicado en 2013

A pilot study of adalimumab in infliximab-allergic patients

artículo científico publicado en 2004

Aberrant expression of the polarity complex atypical PKC and non-muscle myosin IIA in active and inactive inflammatory bowel disease.

artículo científico publicado en 2011

An evidence-based systematic review on medical therapies for inflammatory bowel disease

artículo científico publicado en 2011

Anti-TNF failures in Crohn's disease.

artículo científico publicado en 2011

Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.

artículo científico publicado en 2011

Antibodies to I2 predict clinical response to fecal diversion in Crohn's disease

artículo científico publicado en 2006

Antibodies to tumor necrosis factor-alpha in the treatment of Crohn's disease.

artículo científico publicado en 2005

Back to the beginning: restarting infliximab in inflammatory bowel disease patients with prior loss of response

artículo científico publicado en 2014

Biological markers in inflammatory bowel disease: practical consideration for clinicians.

artículo científico publicado en 2009

Biomarkers in inflammatory bowel disease.

artículo científico publicado en 2004

Certolizumab pegol in patients with moderate to severe Crohn's disease and secondary failure to infliximab

artículo científico publicado en 2010

Chromoendoscopy Is More Effective Than Standard Colonoscopy in Detecting Dysplasia During Long-term Surveillance of Patients With Colitis.

artículo científico publicado en 2015

Chromoendoscopy and Advanced Imaging Technologies for Surveillance of Patients with IBD.

artículo científico publicado en 2012

Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial.

artículo científico publicado en 2008

Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection.

artículo científico publicado en 2009

Colorectal Tumors From Different Racial and Ethnic Minorities Have Similar Rates of Mismatch Repair Deficiency.

artículo científico publicado en 2016

Combination therapy with infliximab and immunomodulators: is the glass half empty?

artículo científico publicado en 2008

Commentary: Golimumab in Moderate-to-Severe Ulcerative Colitis

artículo científico publicado en 2014

Concentrations of 6-thioguanine nucleotide correlate with trough levels of infliximab in patients with inflammatory bowel disease on combination therapy.

artículo científico publicado en 2015

Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine.

artículo científico publicado en 2006

Crohn's disease in patients who fail infliximab therapy: what does the future hold?

artículo científico publicado en 2007

DDS Perspective: My Take on Therapeutic Drug Monitoring in IBD

scientific article published on 01 December 2019

DDS Profile: Maria T. Abreu, MD

scientific article published on 01 December 2019

Deciphering the genetic code of gastrointestinal diseases among African Americans

artículo científico publicado en 2015

Defining subtypes of Crohn's disease patients: the ground work for translational research in inflammatory bowel disease.

artículo científico publicado en 2003

Design issues and outcomes in IBD clinical trials

artículo científico publicado en 2005

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

artículo científico publicado en 2011

Development of Advanced Imaging Criteria for the Endoscopic Identification of Inflammatory Polyps.

artículo científico publicado en 2015

Diagnosis of colitis: making the initial diagnosis.

artículo científico publicado en 2007

Diet and Inflammatory Bowel Disease.

artículo científico publicado en 2015

Diet as Adjunctive Treatment for Inflammatory Bowel Disease: Review and Update of the Latest Literature

artículo científico publicado en 2019

Diet as a Trigger or Therapy for Inflammatory Bowel Diseases.

artículo científico publicado en 2016

Differential abundance of CK1α provides selectivity for pharmacological CK1α activators to target WNT-dependent tumors

artículo científico publicado en 2017

Early clinical experience with adalimumab in treatment of inflammatory bowel disease with infliximab-treated and naïve patients.

artículo científico publicado en 2008

Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel disease.

artículo científico publicado en 2004

Editorial: migration studies to determine risk and cause of inflammatory bowel disease-authors' reply.

artículo científico publicado en 2017

Endoscopy in Inflammatory Bowel Disease

artículo científico publicado en 2016

Epithelial Toll-like receptors and their role in gut homeostasis and disease

artículo científico publicado en 2020

Exercise attenuates PCB-induced changes in the mouse gut microbiome.

artículo científico publicado en 2013

Exposing the Achilles Heel of Antibiotic Therapy for Pouchitis Using Microbial Function and Composition

scientific article published on 19 December 2019

Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot study

artículo científico publicado en 2009

Fluid supplementation accelerates epithelial repair during chemical colitis

artículo científico publicado en 2019

Gastrointestinal malignancy and the microbiome.

artículo científico publicado en 2014

Genetic Characterization and Influence on Inflammatory Bowel Disease Expression in a Diverse Hispanic South Florida Cohort

artículo científico publicado en 2017

Genetics in Diagnosing and Managing Inflammatory Bowel Disease ⬇️

artículo científico publicado el 24 de febrero de 2012

Gut microbes in Crohn's disease: getting to know you better?

scientific article published on 01 February 2008

Harnessing the power of bacteria to protect the gut

artículo científico publicado en 2008

Higher Adalimumab Levels Are Associated with Histologic and Endoscopic Remission in Patients with Crohn's Disease and Ulcerative Colitis

artículo científico publicado en 2016

Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease.

artículo científico publicado en 2017

Hispanics Coming to the US Adopt US Cultural Behaviors and Eat Less Healthy: Implications for Development of Inflammatory Bowel Disease

article

Host-microbe interactions in the small bowel

artículo científico publicado en 2015

Immunologic regulation of toll-like receptors in gut epithelium.

artículo científico publicado en 2003

In silico and Ex vivo approaches identify a role for toll-like receptor 4 in colorectal cancer

artículo científico publicado en 2014

Increased toll-like receptor 4 in cerebral endothelial cells contributes to the astrocyte swelling and brain edema in acute hepatic encephalopathy.

artículo científico publicado en 2013

Inflammatory Cytokine Profile in Crohn's Disease Nonresponders to Optimal Antitumor Necrosis Factor Therapy

artículo científico publicado en 2018

Inflammatory bowel disease is associated with an increased incidence of cardiovascular events.

artículo científico publicado en 2011

Inflammatory bowel disease is presenting sooner after immigration in more recent US immigrants from Cuba.

artículo científico publicado en 2017

Infliximab in the treatment of medically refractory indeterminate colitis

artículo científico publicado en 2003

Initiation of inflammatory tumorigenesis by CTLA4 insufficiency due to type 2 cytokines.

artículo científico publicado en 2018

Innate immunity in the small intestine

artículo científico publicado en 2012

Intestinal Epithelial Toll-Like Receptor 4 Signaling Affects Epithelial Function and Colonic Microbiota and Promotes a Risk for Transmissible Colitis

artículo científico publicado en 2016

Intestinal exposure to PCB 153 induces inflammation via the ATM/NEMO pathway

artículo científico publicado en 2017

Investigation of Microbiota Alterations and Intestinal Inflammation Post-Spinal Cord Injury in Rat Model

artículo científico publicado en 2018

Is genetic testing in IBD ready for prime time?

artículo científico publicado en 2004

Letter: Cuban immigrants to the US developing IBD have a progressive shortening of the lag between time of arrival and disease onset. Authors' reply.

artículo científico publicado en 2017

Lipopolysaccharide potentiates polychlorinated biphenyl-induced disruption of the blood-brain barrier via TLR4/IRF-3 signaling

artículo científico publicado en 2012

Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density

artículo científico publicado en 2004

Mesalamine (5-aminosalicylic acid) therapy well tolerated in a patient with aspirin hypersensitivity and ulcerative colitis.

artículo científico publicado en 2011

Morphine tolerance is attenuated in germfree mice and reversed by probiotics, implicating the role of gut microbiome

artículo científico publicado en 2019

New insights into the pathogenesis of inflammatory bowel disease.

artículo científico publicado en 2004

Optimizing therapy with 6-mercaptopurine and azathioprine: to measure or not to measure? ⬇️

artículo científico publicado el 1 de septiembre de 2010

Pathogen recognition receptors, cancer and inflammation in the gut.

artículo científico publicado en 2009

Phenotypic Manifestations of Inflammatory Bowel Disease Differ Between Hispanics and Non-Hispanic Whites: Results of a Large Cohort Study ⬇️

artículo científico publicado el 18 de diciembre de 2012

Practical techniques for detection of Toll-like receptor-4 in the human intestine.

artículo científico publicado en 2009

Predictive factors for clinically actionable computed tomography findings in inflammatory bowel disease patients seen in the emergency department with acute gastrointestinal symptoms.

artículo científico publicado en 2013

Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids.

artículo científico publicado en 2014

Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine induction.

artículo científico publicado en 2017

Reclassifying Pseudopolyps in Inflammatory Bowel Disease: Histologic and Endoscopic Description in the New Era of Mucosal Healing ⬇️

artículo científico publicado en 2019

Regulation of Toll-like receptor 4-associated MD-2 in intestinal epithelial cells: a comprehensive analysis.

artículo científico publicado en 2009

Reliability and initial validation of the ulcerative colitis endoscopic index of severity

artículo científico publicado en 2013

Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study

scientific article published on 01 October 2007

Role of vascular endothelial growth factor and angiopoietin systems in serum of Crohnʼs disease patients

artículo científico publicado en 2008

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

artículo científico publicado en 2020

Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab

artículo científico publicado en 2005

Selective leukocyte apheresis for the treatment of inflammatory bowel disease.

artículo científico publicado en 2007

Serologies in Crohn's disease: can we change the gray zone to black and white?

artículo científico publicado en 2006

Serum Amyloid A as a Surrogate Marker for Mucosal and Histologic Inflammation in Patients with Crohn's Disease.

artículo científico publicado en 2016

Stool phospholipid signature is altered by diet and tumors

artículo científico publicado en 2014

TLR4 activates the β-catenin pathway to cause intestinal neoplasia

artículo científico publicado en 2013

The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS].

artículo científico publicado en 2015

The Microbiota and the Immune Response: What Is the Chicken and What Is the Egg?

scientific article published on 05 April 2019

The Viral Mimetic Polyinosinic:Polycytidylic Acid Alters the Growth Characteristics of Small Intestinal and Colonic Crypt Cultures

artículo científico publicado en 2015

The Xenobiotic Transporter Mdr1 Enforces T Cell Homeostasis in the Presence of Intestinal Bile Acids.

artículo científico publicado en 2017

The Ying and Yang of bacterial signaling in necrotizing enterocolitis

scientific article published on 21 November 2009

The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study.

artículo científico publicado en 2015

The genetics and pathogenesis of inflammatory bowel disease

artículo científico

The impact of Hispanic ethnicity and race on post-surgical complications in patients with inflammatory bowel disease.

artículo científico publicado en 2013

The impact of anesthesia providers on major morbidity following screening colonoscopies.

artículo científico publicado en 2015

The incidence and risk factors for developing depression after being diagnosed with inflammatory bowel disease: a cohort study.

artículo científico publicado en 2014

The innate immune system and inflammatory bowel disease.

artículo científico publicado en 2015

The multimatrix mesalamine formulation.

artículo científico publicado en 2007

The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease.

artículo científico publicado en 2008

The pathogenesis of inflammatory bowel disease: translational implications for clinicians.

artículo científico publicado en 2002

The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia

artículo científico publicado en 2010

The spectrum of gastrointestinal toxicity and effect on disease activity of selective cyclooxygenase-2 inhibitors in patients with inflammatory bowel disease.

artículo científico publicado en 2004

Therapeutic drug monitoring in patients with inflammatory bowel disease

artículo científico publicado en 2014

Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function.

artículo científico publicado en 2010

Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis

scientific article published on 01 May 2005

Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.

artículo científico publicado en 2009

Transcriptional Behavior of Regulatory T Cells Predicts IBD Patient Responses to Vedolizumab Therapy

artículo científico publicado en 2022

Translational research in inflammatory bowel disease.

artículo científico publicado en 2006

Treating Inflammatory Bowel Disease in Pregnancy: The Issues We Face Today.

artículo científico

Treatment With Infliximab Is Associated With Increased Markers of Bone Formation in Patients With Crohn??s Disease

scientific article published on 01 January 2006

United States-Cuba Research Collaborations: Opening Bridges for Gastroenterology

artículo científico publicado en 2017

Update on idiopathic colitides.

artículo científico publicado en 2013

Updates in mucosal immunology for inflammatory bowel diseases

artículo científico publicado en 2018

Use of Cancer Stem Cells to Investigate the Pathogenesis of Colitis-associated Cancer

artículo científico publicado en 2016

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

artículo científico publicado en 2019

What are toll-like receptors and what role may they have in IBD?

scientific article published on 01 October 2008

What is the role and significance of serum and stool biomarkers in the diagnosis of IBD?

scientific article published on 01 October 2008

[The role of translational research in inflammatory bowel disease]

artículo científico publicado en 2007

Lista de obras de

6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease.

A Noninvasive Method to Assess Mucosal Healing in Patients* With Crohn’s Disease.

A Personalized Approach to Managing Inflammatory Bowel Disease

A call for investment in education of US minorities in the 21(st) century.

A pilot study of adalimumab in infliximab-allergic patients

Aberrant expression of the polarity complex atypical PKC and non-muscle myosin IIA in active and inactive inflammatory bowel disease.

An evidence-based systematic review on medical therapies for inflammatory bowel disease

Anti-TNF failures in Crohn's disease.

Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.

Antibodies to I2 predict clinical response to fecal diversion in Crohn's disease

Antibodies to tumor necrosis factor-alpha in the treatment of Crohn's disease.

Back to the beginning: restarting infliximab in inflammatory bowel disease patients with prior loss of response

Biological markers in inflammatory bowel disease: practical consideration for clinicians.

Biomarkers in inflammatory bowel disease.

Certolizumab pegol in patients with moderate to severe Crohn's disease and secondary failure to infliximab

Chromoendoscopy Is More Effective Than Standard Colonoscopy in Detecting Dysplasia During Long-term Surveillance of Patients With Colitis.

Chromoendoscopy and Advanced Imaging Technologies for Surveillance of Patients with IBD.

Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial.

Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection.

Colorectal Tumors From Different Racial and Ethnic Minorities Have Similar Rates of Mismatch Repair Deficiency.

Combination therapy with infliximab and immunomodulators: is the glass half empty?

Commentary: Golimumab in Moderate-to-Severe Ulcerative Colitis

Concentrations of 6-thioguanine nucleotide correlate with trough levels of infliximab in patients with inflammatory bowel disease on combination therapy.

Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine.

Crohn's disease in patients who fail infliximab therapy: what does the future hold?

DDS Perspective: My Take on Therapeutic Drug Monitoring in IBD

DDS Profile: Maria T. Abreu, MD

Deciphering the genetic code of gastrointestinal diseases among African Americans

Defining subtypes of Crohn's disease patients: the ground work for translational research in inflammatory bowel disease.

Design issues and outcomes in IBD clinical trials

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

Development of Advanced Imaging Criteria for the Endoscopic Identification of Inflammatory Polyps.

Diagnosis of colitis: making the initial diagnosis.

Diet and Inflammatory Bowel Disease.

Diet as Adjunctive Treatment for Inflammatory Bowel Disease: Review and Update of the Latest Literature

Diet as a Trigger or Therapy for Inflammatory Bowel Diseases.

Differential abundance of CK1α provides selectivity for pharmacological CK1α activators to target WNT-dependent tumors

Early clinical experience with adalimumab in treatment of inflammatory bowel disease with infliximab-treated and naïve patients.

Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel disease.

Editorial: migration studies to determine risk and cause of inflammatory bowel disease-authors' reply.

Endoscopy in Inflammatory Bowel Disease

Epithelial Toll-like receptors and their role in gut homeostasis and disease

Exercise attenuates PCB-induced changes in the mouse gut microbiome.

Exposing the Achilles Heel of Antibiotic Therapy for Pouchitis Using Microbial Function and Composition

Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot study

Fluid supplementation accelerates epithelial repair during chemical colitis

Gastrointestinal malignancy and the microbiome.

Genetic Characterization and Influence on Inflammatory Bowel Disease Expression in a Diverse Hispanic South Florida Cohort

Genetics in Diagnosing and Managing Inflammatory Bowel Disease ⬇️

Gut microbes in Crohn's disease: getting to know you better?

Harnessing the power of bacteria to protect the gut

Higher Adalimumab Levels Are Associated with Histologic and Endoscopic Remission in Patients with Crohn's Disease and Ulcerative Colitis

Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease.

Hispanics Coming to the US Adopt US Cultural Behaviors and Eat Less Healthy: Implications for Development of Inflammatory Bowel Disease

Host-microbe interactions in the small bowel

Immunologic regulation of toll-like receptors in gut epithelium.

In silico and Ex vivo approaches identify a role for toll-like receptor 4 in colorectal cancer

Increased toll-like receptor 4 in cerebral endothelial cells contributes to the astrocyte swelling and brain edema in acute hepatic encephalopathy.

Inflammatory Cytokine Profile in Crohn's Disease Nonresponders to Optimal Antitumor Necrosis Factor Therapy

Inflammatory bowel disease is associated with an increased incidence of cardiovascular events.

Inflammatory bowel disease is presenting sooner after immigration in more recent US immigrants from Cuba.

Infliximab in the treatment of medically refractory indeterminate colitis

Initiation of inflammatory tumorigenesis by CTLA4 insufficiency due to type 2 cytokines.

Innate immunity in the small intestine

Intestinal Epithelial Toll-Like Receptor 4 Signaling Affects Epithelial Function and Colonic Microbiota and Promotes a Risk for Transmissible Colitis

Intestinal exposure to PCB 153 induces inflammation via the ATM/NEMO pathway

Investigation of Microbiota Alterations and Intestinal Inflammation Post-Spinal Cord Injury in Rat Model

Is genetic testing in IBD ready for prime time?

Letter: Cuban immigrants to the US developing IBD have a progressive shortening of the lag between time of arrival and disease onset. Authors' reply.

Lipopolysaccharide potentiates polychlorinated biphenyl-induced disruption of the blood-brain barrier via TLR4/IRF-3 signaling

Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density

Mesalamine (5-aminosalicylic acid) therapy well tolerated in a patient with aspirin hypersensitivity and ulcerative colitis.

Morphine tolerance is attenuated in germfree mice and reversed by probiotics, implicating the role of gut microbiome

New insights into the pathogenesis of inflammatory bowel disease.

Optimizing therapy with 6-mercaptopurine and azathioprine: to measure or not to measure? ⬇️

Pathogen recognition receptors, cancer and inflammation in the gut.

Phenotypic Manifestations of Inflammatory Bowel Disease Differ Between Hispanics and Non-Hispanic Whites: Results of a Large Cohort Study ⬇️

Practical techniques for detection of Toll-like receptor-4 in the human intestine.

Predictive factors for clinically actionable computed tomography findings in inflammatory bowel disease patients seen in the emergency department with acute gastrointestinal symptoms.